-
Evidence for the identification of lymphocyte activating factor as the adherent cell-derived mediator responsible for enhanced antibody synthesis by nude mouse spleen cells.
Cell Immunol. 1978 Jan;35(1):92-8
PMID: 620430
-
WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.
Immunol Invest. 1990 Feb;19(1):69-79
PMID: 2110931
-
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
Science. 1986 May 23;232(4753):977-80
PMID: 3754653
-
Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones.
Science. 1986 Aug 8;233(4764):652-4
PMID: 3014662
-
A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.
J Immunol Methods. 1986 Dec 4;95(1):99-105
PMID: 3782828
-
A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.
N Engl J Med. 1987 Sep 10;317(11):653-8
PMID: 3306374
-
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
Nature. 1987 Dec 17-23;330(6149):662-4
PMID: 3317066
-
Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone.
J Immunol. 1988 Mar 15;140(6):1895-902
PMID: 3257992
-
Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
J Clin Invest. 1988 Apr;81(4):1162-72
PMID: 3258319
-
C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha.
J Exp Med. 1988 Jul 1;168(1):443-8
PMID: 3260938
-
In vivo administration of IL-1 induces thymic hypoplasia and increased levels of serum corticosterone.
J Immunol. 1988 Sep 1;141(5):1456-63
PMID: 3261749
-
Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.
Eur J Immunol. 1988 Aug;18(8):1259-64
PMID: 3138137
-
Tumor necrosis factor and the acute metabolic response to tissue injury in man.
J Clin Invest. 1988 Oct;82(4):1321-5
PMID: 3139712
-
Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages.
Am J Pathol. 1988 Dec;133(3):564-72
PMID: 3202118
-
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.
J Exp Med. 1989 Jan 1;169(1):333-8
PMID: 2783334
-
Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.
Eur J Immunol. 1989 Feb;19(2):301-5
PMID: 2784766
-
Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.
J Leukoc Biol. 1989 May;45(5):416-21
PMID: 2651547
-
The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
Pharm Res. 1988 Mar;5(3):129-39
PMID: 3072553
-
The beta form is the dominant interleukin 1 released by murine peritoneal macrophages.
Biochem Biophys Res Commun. 1989 Apr 14;160(1):404-8
PMID: 2653321
-
Kinetics and parameters of the induction of interleukin 1 secretion by rat Kupffer cells.
J Clin Lab Immunol. 1988 Nov;27(3):127-32
PMID: 2854570
-
IL-6 is an intermediate in IL-1-induced thymocyte proliferation.
J Immunol. 1989 Jun 15;142(12):4335-8
PMID: 2786028
-
In vivo dynamics of murine tumor necrosis factor-alpha gene expression. Kinetics of dexamethasone-induced suppression.
Lab Invest. 1989 Jun;60(6):766-71
PMID: 2733382
-
Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models.
Infect Immun. 1989 Oct;57(10):3009-13
PMID: 2777371
-
Biologic and immunohistochemical analysis of macrophage interleukin- 1 alpha, - 1 beta, and tumor necrosis factor production during the peritoneal exudative response.
J Leukoc Biol. 1989 Dec;46(6):529-37
PMID: 2809418
-
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.
J Exp Med. 1989 Nov 1;170(5):1627-33
PMID: 2809510
-
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.
J Exp Med. 1989 Dec 1;170(6):1859-67
PMID: 2584928
-
Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations.
Am J Pathol. 1990 Jan;136(1):49-60
PMID: 2297050
-
Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.
J Immunol. 1978 May;120(5):1497-503
PMID: 149171